Topical hemostatic agent

This page covers all Topical hemostatic agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Fibrinogen (Factor I) and thrombin (Factor IIa), Fibrinogen.

Targets

Fibrinogen (Factor I) and thrombin (Factor IIa) · Fibrinogen

Marketed (5)

• Blood Stopper (Ankaferd) · Ankara Ataturk Sanatorium Training and Research Hospital · Hemostasis / Surgery
  Ankaferd Blood Stopper is a topical hemostatic agent that promotes rapid blood clotting through a combination of plant-derived proteins and minerals that enhance the coagulation cascade.
• EVARREST™ · Ethicon, Inc. · Surgery/Hemostasis
  EVARREST is a topical hemostatic agent that combines thrombin and fibrinogen to form a stable clot at the surgical site.
• Haemostatic solution "Haemoblock" application · Ryazan State Medical University · Hemostasis/Surgery
  Haemoblock is a topical haemostatic agent that promotes blood clotting and wound hemostasis through physical and biochemical mechanisms.
• Thrombin JMI · University of Kansas Medical Center · Hemostasis/Surgery
  Thrombin JMI is a topical thrombin preparation that directly converts fibrinogen to fibrin to promote blood clotting and hemostasis at wound sites.
• Patients receive microporous polysaccharide hemospheres. · Fundación para la Investigación del Hospital Clínico de Valencia · Surgery/Hemostasis
  Microporous polysaccharide hemospheres are biocompatible particles that promote hemostasis by providing a physical scaffold for blood clotting and platelet aggregation.